Hengrui Medicine (01276): National Medical Products Administration approved and issued the "Drug Clinical Trial Approval Notice" for HRS-7172 tablets.

Zhitong Finance APP News, Hengrui Medicine (01276) announced that recently, the company received the approval notice for the drug clinical trial of HRS-7172 tablets issued by the National Medical Products Administration (hereinafter referred to as the "National Medical Products Administration"), and will soon start clinical trials.